Loading clinical trials...

Personalized Medicine for Membranous Nephropathy | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT03804359

Personalized Medicine for Membranous Nephropathy

Randomized, open label, multicentre (20 sites), prospective trial comparing the efficacy of two therapeutic strategies to obtain clinical remission 1 year after diagnosis of Idiopathic Membranous Neph...

Lead sponsor: Centre Hospitalier Universitaire de Nice•19 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGNA

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

NCT07516964 · Nephrotic Syndrome With Edema (Diagnosis), Minimal Change Nephrotic Syndrome, and more

RECRUITINGPhase 3

Different Immunosuppressive Treatment in iMN

NCT04745728 · Idiopathic Membranous Nephropathy

UNKNOWNNA

Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

NCT05782933 · Idiopathic Membranous Nephropathy

UNKNOWN

Prognostic Model of Rituximab in the Treatment of MN

NCT05667909 · Idiopathic Membranous Nephropathy

UNKNOWNNA

Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy

NCT03864250 · Tacrolimus, Idiopathic Membranous Nephropathy, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 25, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment68

Start dateJan 2020

Last updatedJul 25, 2025

Condition

Idiopathic Membranous Nephropathy

Locations shown

CHU D'amiens Hôpital Sud

Amiens

CHU Besançon

Besançon

Hôpital universitaire La Cavale Blanche

Brest

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions